All News

Each additional month of breastfeeding beyond 3 months correlated with a significantly lower child BMIz, especially for mothers identified as overweight or obese.

Findings showed that IBD phenotype varied by race, although foreign-born participants of all races showed evidence of later onset and milder disease.

Your daily dose of the clinical news you may have missed.

Screening for fibrosis in persons at risk of ALD and MASLD led to sustained improvements in lifestyle, eg, reduced alcohol consumption, weight loss, and increased exercise.

The American College of Gastroenterology's new guidelines focus on improved prognosis through early detection, improved accuracy in monitoring,

Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.

More than half of adults with moderate to severe UC maintained clinical and endoscopic remission at 4 years; nearly all no longer required corticosteroids, authors reported.

Your daily dose of the clinical news you may have missed.

The best defense against long COVID remains COVID-19 vaccination. This short slide show highlights long COVID symptoms and CDC vaccination recommendations.

Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.

Your daily dose of the clinical news you may have missed.

A recent review analyzed the effectiveness of nonpharmacologic therapies for neuropathic pain in older adults. Results in our new slide show.

The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.

Use of dupilumab also eliminated the need for use of a rescue inhaler in more than one-third of treated patients and the number of inhalations needed for others.

AXIOMATIC-SSP is considered the largest clinical trial of activated factor XIa inhibition added to standard antiplatelet therapy for secondary stroke prevention.

Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.

The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.

Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.